Preventive Medicine Conference Market Analysis and Reports | UK Conference Series

Market Analysis - Preventive Medicine Conference 2020

Market Analysis:                                                                                                                

The major objective of preventive medicine is the nonappearance of disease, be it by forestalling the occurrence of a disease or by halting a disease thereby reducing the resulting complications after its beginning.  The challenge that is faced by preventive medicine is to motivate the individual to make prevention a practice. The measure taken for disease anticipation and health promotion is called preventive medicine, as way round opposite to treatment of symptoms and diseases. Just as health incorporates an assortment of physical and mental states, so does disease, which is affected by lifestyle, external or genetic factors. Disease prevention depends on anticipatory activities that can be organized as essential, optional, and tertiary prevention.

Market Scenario and Overview:

Preventive Medicine Market is isolated topographically into regions Western Europe, Eastern Europe, North America, Latin America, Asia-Pacific, and the Middle East. North America is the biggest and quickest developing business sector for preventive healthcare technologies and services during the forecast period of 2014 to 2020.  Asia-Pacific and the Middle East and others are experiencing low growth now but are expected to gain potential markets in the coming future. The anticipation from the global preventive medicine market is to reach USD 432.4 billion by 2024. The market is expected to extend at a 9.70% CAGR from 2014 to 2020, with its value rising from US$72.8 billion in 2013 to US$144.8 billion by 2020.

 

Source: Preventive Medicine 2020 Internal   

Regional Analysis of Preventive medicine and Public Health Services

USA: North America being the biggest and the fastest developing region is fuelled by growing awareness, supportive reimbursement policies, and the presence of several leading players. Currently, North America holds almost half of the global market share with 48 % and is expected to continue to dominate in the forecast too.

Europe: Europe is the second largest for preventive healthcare market and services. High healthcare spending per capita and developed economies and in countries like Germany and France are the driving factors for market growth in the region.  European preventive market is able to grow because of the achievements of the high-risk factor epidemiology in the region. Europe holds 37% of Global market share.

The Middle East and Asia Specific: Asia-Pacific and Rest of the World are expected to be potential markets in the future, with the current market estimated to be low, holding only 15% of the share.

 

Source: Preventive Medicine 2020 Internal   

Key Players in Preventive Medicine and Public Health Market:

Top Preventive Medicines Organisations

Counsyl, Inc.,USAHuneo, USAOmada Health, USAHealth Tap, USAGlaxoSmithKline Plc. USA,  Abbott LaboratoriesKindred Healthcare, U.S.A&D Company, JapanLinde Group, Germany, U.S.Kinnser Software, Inc., U.S.Fresenius SE & Co. KGaA GermanyOmron Healthcare, JapanMcKesson Corporation, U.S., Apria Healthcare Group, U.S.Philips Healthcare, NetherlandsJournal Of Preventive Medicine and Public Health.

 

Source: Preventive Medicine 2020 Internal    

Top Preventive Medicines Institutions:

Ohio State University, Columbus, OhioUniversity of Iowa, Iowa City, Iowa University of Illinois, Chicago, IllinoisUniversity of Alabama, Birmingham, AlabamaGeorge Washington University, Washington, D.C.University of TexasHouston Health Sciences Centre, HoustonYale UniversityTulane University, New OrleansLouisiana University of Pittsburgh, PittsburghPenn Sylvia Boston University, BostonMassachusetts University of California, Los Angeles CaliforniaUniversity of Minnesota, MinneapolisBerkley Emory University, AtlantaGeorgia Wolfson Institute of Preventive Medicine, LondonImperial College, LondonThe London School of Medicine and Dentistry, LondonLister Institute of Preventive Medicine, UKThe Leibniz Institute for Prevention Research and Epidemiology, BremenDanube University Krems, AustriaUniversity of East Anglia, Anglia.

Top Healthcare Societies:

European society of preventive medicine, EuropeBritish Geriatrics Society, EnglandEuropean medical associationEurope, Preventive Medicine Society, EuropeJoint British Society, EnglandSociety for Veterinary Epidemiology and Preventive Medicine (SVEPM)EuropePreventive Medicine and Public Health, ItalyThe American Society for Preventive Cardiology, USAEuropean lifestyle medicine association, EuropeAerospace medical association, USAAssociation for prevention and research, EuropeEuropean Union geriatric medicine society, EuropeThe Center for Medicine, Society and Prevention, USAMedical Society Consortium on Climate and Health, USAInternational Academy of preventive medicine, EuropePreventive Medicine Organisation, USA, Italian Society of HygieneWilderness Medical Society practice guidelines for the prevention and treatment of frostbite.

 

Source: Preventive Medicine 2020 Internal  

Conclusion:

Preventive Medicine and Public Health market have a lot to offer to the Preventive Medicine Specialists, Public Health professionals, Physicians, pharmaceutical producers, etc. It has already made an impact in developed countries like Europe, USA, Canada, and Australia.

Development of the market, the broadcasting of knowledge can only occur through international meetings and conferences. The 12th Edition of International Conference on Preventive Medicine and Public health happening on March 18-19, 2020 in London, UK will address the recent advancements happening in this field with a series of key Notes, Plenary sessions, Workshops, Symposiums and discussions represented by eminent speakers from more than 40 nations.

Disclaimer:

The statistics developed in this report is anticipated only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This data does not constitute administrative, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no liability for any loss or damage that might result from reliance on the reported information or from its use.